LP-212 SLE overlap with psoriatic arthritis successfully treated with secukinumab

LP-212 SLE overlap with psoriatic arthritis successfully treated with secukinumab

Bibliographic Details
Main Author:	Athina Theodoridou
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-07-01
Series:	Lupus Science and Medicine

Similar Items

Secukinumab for ankylosing spondylitis and psoriatic arthritis
by: Lubrano E, et al.
Published: (2016-10-01)

Treatment of psoriatic arthritis with secukinumab: a case series
by: Stefania Nicola, et al.
Published: (2018-11-01)

Treatment with secukinumab in multi-comorbid patients with psoriatic arthritis
by: Ombretta Viapiana, et al.
Published: (2018-12-01)

Experience in using secukinumab in patients with axial psoriatic arthritis
by: E. E. Gubar, et al.
Published: (2020-11-01)

Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study
by: Sara Alonso, et al.
Published: (2021-05-01)

Is secukinumab effective for psoriatic arthritis with insufficient response to initial treatment?
by: Soledad Venegas-Iribarren, et al.
Published: (2017-12-01)

SUCCESSFUL USE OF AN INTERLEUKIN 17 INHIBITOR (SECUKINUMAB) IN THE TREATMENT OF ISOLATED DESTRUCTIVE ENTHESITIS IN PSORIATIC ARTHRITIS
by: E. E. Gubar, et al.
Published: (2018-11-01)

Impact of hyperuricaemia on patients with psoriatic arthritis treated with secukinumab in the FUTURE 2–5 and MAXIMISE studies
by: Renaud Felten, et al.
Published: (2023-10-01)

Overlap of Psoriatic Arthritis and Dermatomyositis
by: Christopher Schreiber MD, et al.
Published: (2021-12-01)

Real-world effectiveness and persistence of secukinumab in the treatment of patients with psoriatic arthritis
by: Juan José Alegre-Sancho, et al.
Published: (2023-11-01)

Cutaneous Vasculitis with Gut Involvement During Secukinumab Treatment for Psoriatic Arthritis
by: Clara Chelli, et al.
Published: (2020-03-01)

The effect of secukinumab treatment on hematological parameters in ankylosing spondylitis and psoriatic arthritis
by: Ahmet Karataş, et al.
Published: (2020-10-01)

Real-world data on secukinumab use for psoriatic arthritis and ankylosing spondylitis
by: Ashley Elliott, et al.
Published: (2019-06-01)

Interleukin 17A inhibitor secukinumab in the treatment of patients with psoriatic arthritis
by: N. A. Shostak, et al.
Published: (2022-10-01)

Combining secukinumab and apremilast to successfully treat refractory psoriatic skin and joint disease: A novel approach
by: Muhammad K. Nisar
Published: (2019-01-01)

Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement
by: G. Adami, et al.
Published: (2023-05-01)

Secukinumab in the therapy of psoriasis and psoriatic arthritis: a safe choice in clinical practice
by: Andrea Chiricozzi
Published: (2018-12-01)

Description of the Clinical Case of Adalimumab and Secukinumab Therapy of a Patient with Psoriatic Arthritis
by: V. V. Didenko, et al.
Published: (2021-05-01)

Invasive Aspergillus infection of middle ear in a patient treated with secukinumab, methotrexate, and corticosteroids for psoriasis and psoriatic arthritis
by: Filip Rob, et al.
Published: (2022-10-01)

Effects of TNF-α inhibition secukinumab on active ultrasound-confirmed enthesitis in psoriatic arthritis
by: Ashley Elliott, et al.
Published: (2023-11-01)

Short-term Efficacy and Safety of Secukinumab in Pakistani Patients with Ankylosing Spondylitis and Psoriatic Arthritis
by: Sumera Ghani, et al.
Published: (2023-06-01)

A Machine Learning Approach to Predict Remission in Patients With Psoriatic Arthritis on Treatment With Secukinumab
by: Vincenzo Venerito, et al.
Published: (2022-06-01)

RESULTS OF EVALUATING THE EFFICACY OF SECUKINUMAB VERSUS ADALIMUMAB IN TREATING PSORIATIC ARTHRITIS BY USING THE MATCHING-ADJUSTED INDIRECT COMPARISON METHOD
by: T. V. Korotaeva
Published: (2016-12-01)

Secukinumab treatment in psoriatic patients: Italian experiences
by: Luca Idolazzi
Published: (2018-11-01)

Efficacy and safety of secukinumab in patients with psoriatic arthritis: A meta-analysis of different dosing regimens
by: Kai-Lin Zhang, et al.
Published: (2021-10-01)

Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies
by: Laura C. Coates, et al.
Published: (2019-12-01)

Efficacy and safety of secukinumab over 52 weeks in Chinese psoriasis patients with concomitant psoriatic arthritis
by: Lin Cai, et al.
Published: (2021-11-01)

Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies
by: Coates, L, et al.
Published: (2019)

Acrodermatitis continua of Hallopeau successfully treated with secukinumab
by: Riccardo Balestri, et al.
Published: (2018-11-01)

A clinical case of severe disease burden: an erythrodermic psoriatic patient treated with secukinumab
by: M. Galluzzo, et al.
Published: (2018-11-01)

Secukinumab in multi-failure psoriatic patients: the last hope?
by: M. Magnano, et al.
Published: (2018-08-01)

LP-069 Update of the epidemiology and mortality of juvenile onset SLE and pediatric SLE in Italy
by: Andrea Doria, et al.
Published: (2023-07-01)

LP-091 Neutrophil extracellular traps in APS and SLE
by: Tatiana Reshetnyak, et al.
Published: (2023-07-01)

SCLE-LP overlap syndrome
by: C Shanmuga Sekar, et al.
Published: (2011-01-01)

Le-Lp Overlap Syndrome
by: Chatterjee Saumen, et al.
Published: (2004-01-01)

Effect of secukinumab on the different GRAPPA-OMERACT core domains in psoriatic arthritis: a pooled analysis of 2049 patients
by: Orbai, A-M, et al.
Published: (2019)

Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial
by: Baraliakos, X, et al.
Published: (2022)

The effect of secukinumab on patient-reported outcomes in patients with active psoriatic arthritis in a randomised phase 3 trial
by: Strand, V, et al.
Published: (2022)

Clinically relevant patient clusters identified by machine learning from the clinical development programme of secukinumab in psoriatic arthritis
by: Pournara, E, et al.
Published: (2021)

Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison
by: Philip Mease, et al.
Published: (2019-07-01)